CD155 as a prognostic and predictive biomarker in acute myeloid leukemia

CD155 as a prognostic and predictive biomarker in acute myeloid leukemia

Abstract Background Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy with different molecular and genetic alterations. CD155 is expressed on myeloid cells and serves as a recognition molecule for natural killer (NK) cells to induce cytotoxicity. This study aimed to assess the...

Full description

Saved in:
Bibliographic Details
Main Authors: Ashraf Zeidan Abdalla, Salah Mabrouk Khallaf, Asmaa Mohammed Zahran, Nehal Adel Rayan, Ahmed Refaat Abd Elzaher
Format: Article
Language:English
Published: Springer 2025-05-01
Series:Discover Oncology
Subjects:
Acute Myeloid Leukemia
CD155
Survival
Online Access:https://doi.org/10.1007/s12672-025-02665-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items